Barrow, et al., “Antimycins, Inhibitors of ATP-Citrate Lyase, from a Streptomyces sp.”, Journal of Antibiotics, vol. 50, No. 9, pp. 729 (1997). |
Budavari, et al., “The Merck Index”, Twelfth Edition, Merck and Co., Whitehouse Station, N.J., pp. 120 (1996). |
Shimano, et al., “Total Synthesis of the Antifungal Dilactones UK-2A and UK-3A: The Determination of their Relative and Absolute Configurations, Analog Synthesis and Antifungal Activities,” Tetrahedron Letters, vol. 54, pp. 12745-12774 (1998). |
Ueki, et al., “UK-3A, a Novel Antifungal Antibiotic from Streptomyces sp. 517-02: Fermentation, Isolation, Structural Elucidation and Biological Properties,” Journal of Antibiotics, vol. 50, No. 7, pp. 551 (1997). |
Ueki, et al., “UK-2A, B, and D, Novel Antifungal Antibiotic form Streptomyces sp. 517-02. I. Fermentation, Isolation, and Biological Properties,” Journal of Antibiotics, vol. 49, No. 7, pp. 639 (1996). |
Hanafi, et al., “UK-2A, B, C and D, Novel Antifungal Antibiotic from Streptomyces sp. 517-02,” Journal of Antibiotics, vol. 49, No. 12, pp. 1226 (1996). |
Shimano, et al., “Enantioselective Total Synthesis of the Antifungal Dilactone, UK-2A: The Determination of the Relative and Absolute Configurations,” Tetrahedron Letters vol. 39, pp. 4363-4366 (1998). |